Skip to content
Adam Torkildson – Lifestyle
Author:
Olema Oncology
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 2, 2026
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
March 17, 2026
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 16, 2026
←
Previous Page
1
2